SVAのニュース
SINOVAC DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Sinovac Biotech Ltd. and Encourages Investors to Contact the Firm 2022/10/15 01:00:00 Business Wire
NEW YORK--(BUSINESS WIRE)-- #Action--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Sinovac securities between April 11, 2016 and February 22, 2019, both dates inclusive (the “Class Period”
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Sinovac Biotech Ltd. (SVA) Investors of Class Action Deadline Against 1Globe Capital LLC and to Actively Participate 2022/10/14 15:00:00 Wallstreet:Online
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against 1Globe Capital LLC (“1Globe”) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA) stock between April 11, 2016, and February 22, 2019 (the “Class
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors With Losses to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA 2022/10/04 22:05:00 PR Newswire
NEW YORK, Oct. 4, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of the stock of Sinovac Biotech Ltd. (NASDAQ: SVA) between April 11, 2016 and February 22, 2019, both dates inclusive (the "Class Period"), of the October 17, 2022 lead plaintiff…
Hong Kong reviews proposal to give children mix of BioNTech and Sinovac jabs 2022/09/21 09:06:56 South China Morning Post
Authorities confirm Post report, with health minister Lo Chung-mau and scientific committee to review application to make available BioNTech jab for youngsters.
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA 2022/09/14 08:09:00 PR Newswire
NEW YORK, Sept. 14, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of the stock of Sinovac Biotech Ltd. (NASDAQ: SVA) between April 11, 2016 and February 22, 2019, both dates inclusive (the "Class Period"), of the October 17, 2022 lead…
Sinovac Biotech GAAP EPS of $74.27, revenue of $19.4B 2022/05/02 07:48:59 Seeking Alpha
Sinovac Biotech press release (SVA): FY GAAP EPS of $74.27.Revenue of $19.4B (+3699.5% Y/Y).Non-GAAP adjusted EBITDA was $17.6B in 2021, compared to $229.9M in the prior year.As…
SINOVAC Reports Unaudited Second Half of 2021 Financial Results and Files 2021 Annual Report on Form 20-F 2022/04/29 22:30:00 Business Wire
BEIJING, China--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2021 annual report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2021. The Company also reported its unaudited financial for the second half and full year ended December 31, 2021. Second Half and Full Year 2021 Financial Summary Sales for the six months ended December 31, 2021 we
Vaccines against Omicron approved for clinical trials 2022/04/27 08:47:05 ECNS China News
Two homegrown Omicron-specific COVID-19 vaccine candidates developed by Sinopharm and Sinovac Biotech have been approved for clinical trials by China''s top drug regulator, the two companies said on Tuesday.
Sinovac Biotech''s Omicron-specific vaccine cleared for clinical trial in Hong Kong 2022/04/18 08:29:04 Seeking Alpha
Sinovac Biotech''s (SVA) Omicron-specific vaccine was approved for clinical trials in Hong Kong.Sinovac, a unit of Sinopharm Group (SHTDF) (SHTDY), said preclinical studies showed that…
Sinovac booster shows 98% protection against death/severe COVID in people over 60 in study 2022/03/24 11:08:24 Seeking Alpha
Sinovac Biotech (SVA) said a study in Hong Kong suggested that three shots of its COVID-19 vaccine CoronaVac offered ~98% protection against death or severe illness in people over 60…
Sinovac booster weaker against Omicron - HK study 2021/12/24 00:18:00 Malaysia Kini
Analysis reveals Pfizer-BioNTech vaccine more effective.
Futures Ramp Above 4,700 On Growing Omicron Optimism 2021/12/23 13:06:18 Zero Hedge
Futures Ramp Above 4,700 On Growing Omicron Optimism If you had gone to bed on Thanksgiving after eating a little too much tryptophan and only woken up today, roughly one month later, you would have completely avoided a rollercoaster move in global markets, and much of the omicron panic, with the S&P now trading precisely where it was the night before scattered reports of Omicron in South Africa sparked a global selloff. As of 730am, e-mini S&P futures were trading at exactly 4,700, up 14 points or 0.3% - and once again less than 1% from all time highs - on rising hopes the omicron variant wont impact global growth even as officials remain cautious about its spread, after studies showed its less severe than other strains; Dow Jones futures also rose 0.3% while Nasdaq 100 futures were 0.2% higher. US Treasury yields rose, the 10Y trading at 1.475%, while the USD index traded flat. The pound rose as traders stepped up bets on a Bank of England rate hike. Soaraing European natural gas prices plunged more than 20% as this years rally attracted a flotilla of U.S. cargoes, helping offset lower flows from Russia.
2.3bn Covid shots useless against Omicron study 2021/12/23 11:07:41 Russia Today
A Chinese study has revealed that the vaccine made by Chinas Sinovac Biotech fails to provide adequate protection against the Omicron variant of Covid-19 even after a booster shot has been administered. Read Full Article at RT.com
3 Sinovac shots won''t fully protect against Omicron - study 2021/12/23 10:03:00 Breaking the News 24/7
Three doses of the COVID-19 vaccine developed by Chinese company Sinovac Biotech fail to fully protect against the Omicron coronavirus variant, according to the latest study published on Thursday. Ho…